Manufacturer:
Pfizer
Route of Administration:
Oral
Site of Care:
Outpatient
Website:
Enrollment Forms:
Synergen Prescription Form
Approved Indication:
- prophylaxis of organ rejection in combination with cyclosporine and corticosteroids in patients aged ≥ 13 years receiving renal transplants
- treatment of patients with lymphangioleiomyomatosis
Conditions:
- Solid organ transplant
- lymphangioleiomyomatosis
Therapeutic Area:
- Nephrology
- Pulmonary
- Solid Organ Transplant